Elevated APOBEC mutational signatures implicate chronic injury in etiology of an aggressive head-and-neck squamous cell carcinoma: a case report. by Patel, Jena et al.
Thomas Jefferson University 
Jefferson Digital Commons 
Department of Otolaryngology - Head and Neck 
Surgery Faculty Papers 
Department of Otolaryngology - Head and Neck 
Surgery 
4-30-2021 
Elevated APOBEC mutational signatures implicate chronic injury 
in etiology of an aggressive head-and-neck squamous cell 
carcinoma: a case report. 
Jena Patel 
Nicoline Y. den Breems 
Madalina Tuluc 
Jennifer Johnson 
Joseph M. Curry 
See next page for additional authors 
Follow this and additional works at: https://jdc.jefferson.edu/otofp 
 Part of the Dermatology Commons, Oncology Commons, and the Otolaryngology Commons 
Let us know how access to this document benefits you 
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital 
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is 
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections 
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested 
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been 
accepted for inclusion in Department of Otolaryngology - Head and Neck Surgery Faculty Papers by an authorized 
administrator of the Jefferson Digital Commons. For more information, please contact: 
JeffersonDigitalCommons@jefferson.edu. 
Authors 
Jena Patel, Nicoline Y. den Breems, Madalina Tuluc, Jennifer Johnson, Joseph M. Curry, Andrew P. South, 
and Raymond J. Cho 
Patel et al. J Med Case Reports          (2021) 15:252  
https://doi.org/10.1186/s13256-021-02685-w
CASE REPORT
Elevated APOBEC mutational signatures 
implicate chronic injury in etiology 
of an aggressive head-and-neck squamous cell 
carcinoma: a case report
Jena Patel1* , Nicoline Y. den Breems2, Madalina Tuluc3, Jennifer Johnson4, Joseph M Curry1, 
Andrew P. South5 and Raymond J. Cho6 
Abstract 
Background: Aggressive squamous cell carcinomas (SCCs) present frequently in the context of chronic skin injury 
occurring in patients with the congenital blistering disease recessive dystrophic epidermolysis bullosa. Recently, these 
cancers were shown to harbor mutation signatures associated with endogenous deaminases of the active polynu-
cleotide cytosine deaminase family, collectively termed APOBEC, and  clock-like COSMIC [Catalogue of Somatic Muta-
tions in Cancer] signatures, which are associated with normal aging and might result from cumulative DNA replication 
errors. We present a case of a nasal septal SCC arising in the context of recurrent injury, but also modest past tobacco 
use. Our genetic analysis of this tumor reveals unusually high APOBEC and  clock-like but low tobacco-related COSMIC 
signatures, suggesting that chronic injury may have played a primary role in somatic mutation. This case report dem-
onstrates how signature-based analyses may implicate key roles for certain mutagenic forces in individual malignan-
cies such as head-and-neck SCC, with multiple etiological origins.
Case presentation: We report the case of a 43-year-old male former smoker who presented with congestion and 
swelling following a traumatic nasal fracture. During surgery, the mucosa surrounding the right nasal valve appeared 
abnormal, and biopsies revealed invasive keratinizing SCC. Frozen section biopsies revealed multiple areas to be 
positive for SCC. Gene sequencing showed loss of PTEN (exons 2–8), CDKN2A/B and TP53 (exons 8–9), MYC amplifica-
tion, and BLM S338*. Exome sequencing data also revealed that 36% of mutations matched an APOBEC mutational 
signature (COSMIC signatures 2 and 13) and 53% of mutations matched the  clock-like mutation signature (COSMIC 
signature 5). These proportions place this tumor in the 90th percentile bearing each signature, independently, in a ref-
erence data set combining cutaneous and The Cancer Genome Atlas (TCGA) head and neck SCC data. In contrast, few 
mutations harbored a tobacco-related COSMIC signature 4, representing about the 10th percentile in our reference 
SCC data set. The patient was treated with partial rhinectomy with local flap reconstruction, bilateral neck dissection, 
and adjuvant radiation therapy; the patient remains disease-free to date.
Conclusion: Based on comparative mutational signature analysis, we propose that the history of tobacco use 
and traumatic injury may have collaborated in activating APOBEC enzymes and the  clock-like mutational process, 
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Background
Cutaneous squamous cell carcinomas (SCCs) sometimes 
arise with chronic epithelial injury, such as in patients 
with recessive dystrophic epidermolysis bullosa (RDEB). 
These skin cancers behave more aggressively than ultra-
violet light (UV)-derived skin cancers [1]. Recently, 
cutaneous SCCs from chronically injured epithelium of 
RDEB patients were shown to harbor somatic mutation 
patterns associated with enhanced activity of the apoli-
poprotein B mRNA-editing enzyme catalytic polypep-
tide–like (APOBEC) cytosine deaminases (determined 
by their DNA context rather than the genes in which 
they arise), also known in aggregate as “mutation sig-
natures” [1, 2]. These findings suggest that chronically 
injured cells undergo a predictable form of mutagen-
esis, and that epithelial cancers bearing this signature 
deserve close monitoring. We genetically character-
ized a metastatic head-and-neck SCC of the nasal sep-
tum with clinical symptoms of long-term injury. Exome 
sequencing revealed a sharply enhanced APOBEC 
mutation signature, supporting a model in which these 
mechanisms cause aggressive skin cancers originating 
in chronic wounds. To our knowledge, this is the first 
case report linking specific mutational signatures with 
head-and-neck SCC arising at a site of chronic injury. 
Such cancers should be monitored more closely, and 
potentially clinically evaluated for early dissemination.
Case presentation
A 43-year-old Caucasian man presented with a traumatic 
nasal fracture. He noted difficulty breathing and soreness 
at the right side of the nose, and a 5-year history of mild 
tenderness at the same site. On physical exam, his nose 
was deviated to the right, and nasal endoscopy revealed 
normal-appearing mucosa with some anterior crusting. 
The patient had a 7.5-pack-year smoking history, with 
cessation 13 years earlier. The patient did not have any 
significant medical history otherwise and did not have a 
family history of cancer.
During repair of the fracture, the right external nasal 
valve mucosa appeared ulcerated. Biopsy revealed inva-
sive keratinizing SCC with perineural involvement. 
Subsequent computed tomography (CT) and positron 
emission tomography (PET)/CT imaging showed local 
disease only (Fig.  1). The patient underwent partial rhi-
nectomy with a paramedian forehead flap reconstruc-
tion; negative histopathologic margins were established. 
The lesion spanned 2.4 cm and involved the right lateral 
ultimately leading to cancer formation. Clinical awareness of the relationship between epithelial injury and tumori-
genesis should enhance earlier detection of this particularly aggressive type of cancer.
Keywords: APOBEC, Squamous cell carcinoma, RDEB, Epithelial injury
Fig. 1 Patient imaging findings including head and neck a positron emission tomography–computed tomography (PET-CT) and b CT with 
contrast showing 15.4 mm × 24.1 mm right nasal mass and local disease only
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nasal wall with extension to the septum and invasion 
through the cartilage into the subcutaneous tissues of the 
right ala. On 2-month follow-up, the patient reported a 
new, palpable submandibular lymph node on the right 
side. Fine needle aspiration showed regionally meta-
static disease. Bilateral neck dissection revealed disease 
in one of 56 excised lymph nodes at level 1B; the lymph 
node was 3 cm in size. After surgery, the patient had a 
final pathologic stage of T2N1M0. He underwent adju-
vant radiation therapy using volumetric-modulated arc 
therapy (VMAT) to the nasal cavity and bilateral neck; 
he received a total of 60 Gy in 30 fractions. The patient 
tolerated therapy well, with no interruptions or major 
toxicity. The 5-year overall survival for early-stage T1–T2 
disease was estimated at 58–85%; however, due to limited 
comparison data it was difficult to determine the patient’s 
exact prognosis. To date, the patient has no evidence of 
disease recurrence.
Immunohistochemistry of the tumor was positive for 
cytokeratin and negative for p16 (Fig.  2). Human papil-
loma virus type 16 (HPV16) and HPV18 were negative. 
 FoundationOne® analysis showed loss of PTEN (exons 
2–8), CDKN2A/B and TP53 (exons 8–9), MYC amplifi-
cation, and a BLM S338* truncating mutation. Exome 
sequencing on the Illumina HiSEQ platform with >110× 
nucleotide coverage [1] revealed 435 somatic single-
nucleotide variants. Thirty-six percent of mutations 
matched an apolipoprotein B mRNA-editing enzyme 
catalytic polypeptide–like (APOBEC) mutational sig-
nature (2 and 13), characterized by the presence of C>T 
substitutions (signature 2) and C>G substitutions (signa-
ture 13) (Fig. 3). One-way analysis of variance (ANOVA) 
showed a significant overrepresentation of the APOBEC 
signature (p = 0.000) and underrepresentation of the 
tobacco-related signature (p = 0.001) in the nasal sep-
tal  squamous cell carcinoma (SCC), compared to the 
reference SCC data set. There was no  ultraviolet (UV)-
associated COSMIC signature 7 (associated with large 
numbers of CC>TT dinucleotide mutations) or tobacco-
associated Catalogue of Somatic Mutations in Cancer 
(COSMIC) signature 4 (characterized by CC>AA dinu-
cleotide substitutions); however, there was a substantial 
COSMIC signature 5 (characterized by transcriptional 
strand bias for C>T substitutions at ApTpN context) con-
tribution (53%).
Notably, these data place mutations from our patient’s 
tumor matching an APOBEC mutational signature 2 
and those matching a  clock-like mutation COSMIC sig-
nature 5 each in the 90th percentile of a reference data 
set consisting of The Cancer Genome Atlas (TCGA) 
head-and-neck SCCs and a separate data set of cutane-
ous SCCs (Fig.  4). The top 90th percentile of APOBEC 
signature 2-containing TCGA head-and-neck SCCs 
(shown in brown) are highly represented in the 90th per-
centile of APOBEC COSMIC signature 13-containing 
tumors, confirming their expected concordance (Fig. 3). 
In contrast, few of the reference APOBEC COSMIC sig-
nature 2-elevated group appear in the top 90th percen-
tile of clock-like COSMIC  signature 5 mutations, as do 
our patient’s tumor and like those injury-derived SCCs 
recently reported to arise in an RDEB background [1]. 
Notably, the patient’s tumor also did not harbor any 
tobacco-related COSMIC signature 4 mutations, placing 
it in about the 10th percentile in the reference data set.
Fig. 2 Invasive, p16-negative squamous cell cancer (SCC) of the nasal septum arising in the context of chronic injury. a Hematoxylin and eosin 
staining of SCC (×4 magnification), b ×10 magnification, c p16 staining demonstrating loss of p16 in tumor (black arrow), with preservation of 
signal in stroma (red arrow)
Page 4 of 6Patel et al. J Med Case Reports          (2021) 15:252 
Discussion
SCC can arise from chronic injury, initiated by processes 
ranging from bullous disease to burn injury, a process 
recently linked to the APOBEC nucleic acid editing sys-
tem. Physiologically, APOBEC enzymes possess cytosine 
deaminase activity for RNA and single-stranded DNA 
(ssDNA), facilitating antibody diversification and lipid 
metabolism, and protecting the host from viral infec-
tion [2]. However, whole genome sequencing has dem-
onstrated that these deaminases can be a major source 
of clustered nonrandom genomic mutations in multiple 
types of cancers including prostate and colorectal cancer 
[1, 2, 6].
Our patient’s tumor harbored approximately seven 
mutations per megabase (mB), similar to RDEB cSCCs 
and below the >100 mutations/mB observed in UV-
driven cSCCs. Relative to most head-and-neck SCC and 
cutaneous SCC, this cancer harbors an elevated per-
centage of APOBEC COSMIC signatures 2 and 13 and 
clock-like COSMIC signature 5 mutations. Although the 
patient was a former smoker, there were no COSMIC 
signature 4 mutations, suggesting that this mechanism 
was not as active in this tumor. Therefore, we speculate 
that tumors like our patient’s, which harbor larger pro-
portions of APOBEC and clock-like  mutations relative 
to tobacco-associated mutations, arise from a source of 
chronic injury or inflammation other than tobacco. The 
patient’s extended clinical history of soreness at this site 
suggests a possible source of injury preceding tumor 
development. This hypothetical link between relative 
mutation signatures and causative etiology is testable and 
deserves further evaluation.
While the relative mutation signature interpreta-
tions we present here are largely qualitative, in Fig.  3, 
we develop and present a percentile-based comparative 
analysis in which our patient’s tumor is assessed in the 
context of a large reference data set of signatures from 
similar cancers. This analysis illustrates the rarity of a 
head-and-neck tumor harboring both elevated APOBEC 
and  clock-like mutations, as seen in the patient profiled 
here, and lays groundwork for future comparative quan-
titative analysis of mutation signatures in individual 
Fig. 3 Apolipoprotein B mRNA-editing enzyme catalytic polypeptide–like (APOBEC) mutation signatures are sharply enhanced in a squamous 
cell carcinoma (SCC) arising in a clinical context of nasal septal injury. Column graph shows percentage of mutations matching each of three 
stereotyped patterns (“signatures”)  [3, 4] of nucleotide mutation and context. Catalogue of Somatic Mutations in Cancer (COSMIC) signatures 
2 and 13 (36%) are associated with APOBEC mutagenesis and are detected on average at levels <5% in spontaneous, ultraviolet (UV)-derived 
cutaneous SCCs. COSMIC signature 4 is associated with UV light exposure and mutagenesis. COSMIC signature 5 represents a less specific 
mutagenesis pattern found in many cancer types (clock-like) and associated with normal aging, as well as chronic tissue injury [3]. p values show 
results of a one-way analysis of variance assessing whether the prevalence of a mutation signature is significantly different in the patient’s tumor 
(red) compared to a cohort of 38 UV-induced SCCs (blue) and 279 The Cancer Genome Atlas (TCGA) head-and-neck SCCs (green). This analysis 
demonstrated a significant overrepresentation of the APOBEC signature (p = 0.000) and underrepresentation of the tobacco signature (p = 0.001) 
in our patient’s tumor, compared to the reference data set. Mutational signature assignation from exome sequencing data was performed using the 
deconstructSigs method [5]
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cancers. Future development of APOBEC-inhibitors 
could offer options where chronic injury is clinically 
apparent but difficult to treat [7].
A limitation of this case report and our method 
assessing mutation signatures in individual patients 
is that we cannot determine whether the initial septal 
injury was due to trauma or an endogenous inflamma-
tory process; it is also possible that tobacco exposure 
contributed to re-injury at this site. However, aware-
ness of this relationship between epithelial injury and a 
specific form of mutagenesis should alter clinical man-
agement of SCCs.
Conclusion
An overrepresented APOBEC mutational signature may 
predict aggressive cutaneous SCCs, possibly because of 
parallel, injury-mediated disruption of the microenviron-
ment, warranting thorough surgical extirpation and long-
term monitoring. Development of  APOBEC inhibitors 
could serve as a potential therapy in cases involving 
chronic injury.
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